Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares in GlaxoSmithKline plc purchased at a price of £12.79 per share on 15 April 2010, and Ordinary share ADRs in GlaxoSmithKline plc purchased at a price of $39.29 per ADR on 8 April 2010, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 8 April 2010.
|
Ordinary shares |
ADRs |
Mr A P Witty |
280.57 |
|
Mr J S Heslop |
346.59 |
|
Dr M M Slaoui |
|
236.43 |
Mrs C E Bruck Slaoui |
|
4.56 |
Mr S M Bicknell |
14.65 |
|
Mr J M Clarke |
254.17 |
|
Mr M Dunoyer |
95.73 |
|
Mr E J Gray |
19.47 |
|
Mr D Learmouth |
70.15 |
|
Mr W C Louv |
|
132.82 |
Mr D J Phelan |
|
324.57 |
Dr D Pulman |
|
199.75 |
Mr D S Redfern |
19.47 |
|
Ms C Thomas |
14.65 |
|
Mr J R Stéphenne |
74.41 |
|
The Company was advised of this information on 21 April 2010.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
21 April 2010